These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2433446)

  • 1. Molecular basis for anticancer drug amplification: interaction of phleomycin amplifiers with DNA.
    Strekowski L; Chandrasekaran S; Wang YH; Edwards WD; Wilson WD
    J Med Chem; 1986 Jul; 29(7):1311-5. PubMed ID: 2433446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of bleomycin-mediated degradation of DNA.
    Strekowski L; Strekowska A; Watson RA; Tanious FA; Nguyen LT; Wilson WD
    J Med Chem; 1987 Aug; 30(8):1415-20. PubMed ID: 2441055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential DNA recognition by the enantiomers of 1-Rh(MGP)2 phi: a combination of shape selection and direct readout.
    Franklin SJ; Barton JK
    Biochemistry; 1998 Nov; 37(46):16093-105. PubMed ID: 9819202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A substituent constant analysis of the interaction of substituted naphthalene monoimides with DNA.
    Stevenson KA; Yen SF; Yang NC; Boykin DW; Wilson WD
    J Med Chem; 1984 Dec; 27(12):1677-82. PubMed ID: 6502597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethidium bromide-(dC-dG-dC-dG)2 complex in solution: intercalation and sequence specificity of drug binding at the tetranucleotide duplex level.
    Patel DJ; Canuel LL
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3343-7. PubMed ID: 1068447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction with DNA of unfused aromatic systems containing terminal piperazino substituents. Intercalation and groove-binding.
    Wilson WD; Barton HJ; Tanious FA; Kong SB; Strekowski L
    Biophys Chem; 1990 Apr; 35(2-3):227-43. PubMed ID: 2397274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for bleomycin amplification: conformational and stereoelectronic effects in unfused amplifiers.
    Strekowski L; Mokrosz JL; Tanious FA; Watson RA; Harden D; Mokrosz M; Edwards WD; Wilson WD
    J Med Chem; 1988 Jun; 31(6):1231-40. PubMed ID: 2453673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper(II).bleomycin, iron(III).bleomycin, and copper(II).phleomycin: comparative study of deoxyribonucleic acid binding.
    Povirk LF; Hogan M; Dattagupta N; Buechner M
    Biochemistry; 1981 Feb; 20(3):665-71. PubMed ID: 6163448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-classical intercalation model for a bleomycin amplifier.
    Strekowski L; Wilson WD; Mokrosz JL; Strekowska A; Koziol AE; Palenik GJ
    Anticancer Drug Des; 1988 Mar; 2(4):387-98. PubMed ID: 2452646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of the hydroperoxide of Co(III) phleomycin complexed with d(CCAGGCCTGG)2: evidence for binding by partial intercalation.
    Wu W; Vanderwall DE; Turner CJ; Hoehn S; Chen J; Kozarich JW; Stubbe J
    Nucleic Acids Res; 2002 Nov; 30(22):4881-91. PubMed ID: 12433991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of unfused polyaromatic heterocycles with DNA: intercalation, groove-binding and bleomycin amplification.
    Wilson WD; Tanious FA; Barton HJ; Wydra RL; Jones RL; Boykin DW; Strekowski L
    Anticancer Drug Des; 1990 Feb; 5(1):31-42. PubMed ID: 1690546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of intercalator structure on DNA binding strength: the importance of side chain orientation.
    Wilson WD; Chandrasekaran S; Kusuma S; Boykin DW; Neidle S
    J Biomol Struct Dyn; 1987 Oct; 5(2):327-44. PubMed ID: 3271478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the bithiazole moiety of bleomycin a classical intercalator?
    Hénichart JP; Bernier JL; Helbecque N; Houssin R
    Nucleic Acids Res; 1985 Sep; 13(18):6703-17. PubMed ID: 2414728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-on-off pH luminescence switching and DNA binding properties of a free terpyridine-appended ruthenium complex.
    Zheng ZB; Kang SY; Yi X; Zhang N; Wang KZ
    J Inorg Biochem; 2014 Dec; 141():70-78. PubMed ID: 25226435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifunctional intercalation of antitumor antibiotics BBM-928A and echinomycin with deoxyribonucleic acid. Effects of intercalation on deoxyribonucleic acid degradative activity of bleomycin and phleomycin.
    Huang CH; Prestayko AW; Crooke ST
    Biochemistry; 1982 Jul; 21(15):3704-10. PubMed ID: 6180762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DAPI (4',6-diamidino-2-phenylindole) binds differently to DNA and RNA: minor-groove binding at AT sites and intercalation at AU sites.
    Tanious FA; Veal JM; Buczak H; Ratmeyer LS; Wilson WD
    Biochemistry; 1992 Mar; 31(12):3103-12. PubMed ID: 1372825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H- and 31P-NMR studies of ditercalinium binding to a d(GCGC)2 and d(CCTATAGG)2 minihelices: a sequence specificity study.
    Delepierre M; Milhe C; Namane A; Dinh TH; Roques BP
    Biopolymers; 1991 Feb; 31(3):331-53. PubMed ID: 1868161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intercalator structure on binding strength and base-pair specificity in DNA interactions.
    Wilson WD; Wang YH; Kusuma S; Chandrasekaran S; Boykin DW
    Biophys Chem; 1986 Jul; 24(2):101-9. PubMed ID: 3756304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for DAPI intercalation in CG sites of DNA oligomer [d(CGACGTCG)]2: a 1H NMR study.
    Trotta E; D'Ambrosio E; Ravagnan G; Paci M
    Nucleic Acids Res; 1995 Apr; 23(8):1333-40. PubMed ID: 7753623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of bleomycin-mediated degradation of DNA by polyamines.
    Strekowski L; Mokrosz M; Mokrosz JL; Strekowska A; Allison SA; Wilson WD
    Anticancer Drug Des; 1988 Aug; 3(2):79-89. PubMed ID: 2457380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.